View in EDS HTML Full Text PDF Full Text

Real-world comparative outcomes of darolutamide- versus abiraterone-based triplet therapy for metastatic hormone-sensitive prostate cancer: a retrospective cohort study.

Saved in:
Bibliographic Details
Title: Real-world comparative outcomes of darolutamide- versus abiraterone-based triplet therapy for metastatic hormone-sensitive prostate cancer: a retrospective cohort study.
Authors: Chen IA; Division of Transplant Surgery, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.; Institute of Clinical Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.; School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan.; Division of Urology, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan., Chang RI; Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.; Department of Emergency Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.; School of Medicine, Chung Shan Medical University, Taichung, Taiwan., Yu CC; Division of Urology, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan., Lin TP; Division of Urology, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung 813414, Taiwan.; Institute of Clinical Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan., Yang CY; Institute of Clinical Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan.; Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; International Medical Service Center, Taipei Veterans General Hospital, Taipei, Taiwan.; Center for Intelligent Drug Systems and Smart Bio-devices (IDS2B), National Yang Ming Chiao Tung University, Hsinchu, Taiwan.; Stem Cell Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Source: Therapeutic advances in urology [Ther Adv Urol] 2026 Jul 03; Vol. 18, pp. 17562872261463076. Date of Electronic Publication: 2026 Jul 03 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Sage Publications Country of Publication: England NLM ID: 101487328 Publication Model: eCollection Cited Medium: Print ISSN: 1756-2872 (Print) Linking ISSN: 17562872 NLM ISO Abbreviation: Ther Adv Urol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42405379
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Real-world comparative outcomes of darolutamide- versus abiraterone-based triplet therapy for metastatic hormone-sensitive prostate cancer: a retrospective cohort study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chen+IA%22">Chen IA</searchLink>; Division of Transplant Surgery, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.; Institute of Clinical Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.; School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan.; Division of Urology, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chang+RI%22">Chang RI</searchLink>; Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.; Department of Emergency Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Yu+CC%22">Yu CC</searchLink>; Division of Urology, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lin+TP%22">Lin TP</searchLink>; Division of Urology, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung 813414, Taiwan.; Institute of Clinical Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Yang+CY%22">Yang CY</searchLink>; Institute of Clinical Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan.; Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; International Medical Service Center, Taipei Veterans General Hospital, Taipei, Taiwan.; Center for Intelligent Drug Systems and Smart Bio-devices (IDS2B), National Yang Ming Chiao Tung University, Hsinchu, Taiwan.; Stem Cell Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101487328%22">Therapeutic advances in urology</searchLink> [Ther Adv Urol] 2026 Jul 03; Vol. 18, pp. 17562872261463076. <i>Date of Electronic Publication: </i>2026 Jul 03 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage+Publications%22">Sage Publications </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101487328 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1756-2872 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217562872%22">17562872 </searchLink><i>NLM ISO Abbreviation: </i>Ther Adv Urol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42405379
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/17562872261463076
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 17562872261463076
    Titles:
      – TitleFull: Real-world comparative outcomes of darolutamide- versus abiraterone-based triplet therapy for metastatic hormone-sensitive prostate cancer: a retrospective cohort study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chen IA
      – PersonEntity:
          Name:
            NameFull: Chang RI
      – PersonEntity:
          Name:
            NameFull: Yu CC
      – PersonEntity:
          Name:
            NameFull: Lin TP
      – PersonEntity:
          Name:
            NameFull: Yang CY
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 07
              Text: 2026 Jul 03
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 1756-2872
          Numbering:
            – Type: volume
              Value: 18
          Titles:
            – TitleFull: Therapeutic advances in urology
              Type: main
ResultId 1